| Literature DB >> 35535147 |
Jing Zhang1, Yuxi Li2, Bo Zheng2, Jianxing Qiu3, Xiahuan Chen1, Weiwei Zhou1, Yan Fan1, Meilin Liu1.
Abstract
Purpose: To assess the diagnostic efficiency of a combination of symptoms, residual Syntax score (rSS) and non-invasive tests in elderly post-PCI patients. Patients andEntities:
Keywords: coronary CT angiography; elderly; exercise ECG; percutaneous coronary intervention; residual syntax score
Year: 2022 PMID: 35535147 PMCID: PMC9078441 DOI: 10.2147/IJGM.S357996
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Baseline Characteristics of the Study Participants
| caFFR | All Patients (n=114) | Positive (n=75) | Negative (n=39) | |
|---|---|---|---|---|
| Age (years) | 74.05 ± 8.13 | 74.44 ± 8.44 | 73.31 ± 7.56 | 0.457 |
| Sex (Male) | 109 (95.61%) | 72 (96.00%) | 37 (94.87%) | 0.780 |
| BMI (kg/m2) | 24.81 ± 3.36 | 24.51 ± 3.37 | 25.38 ± 3.30 | 0.125 |
| Hypertension | 82 (71.93%) | 55 (73.33%) | 27 (69.23%) | 0.644 |
| Diabetes mellitus | 41 (35.96%) | 30 (40.00%) | 11 (28.21%) | 0.213 |
| HbA1c (%) | 6.29 ± 1.00 | 6.40 ± 1.16 | 6.09 ± 0.57 | 0.125 |
| Scr (μmol/L) | 91.47 ± 16.62 | 93.22 ± 17.50 | 88.12 ± 14.40 | 0.121 |
| Uric acid (μmol/L) | 346.49 ± 74.76 | 343.69 ± 72.53 | 351.87 ± 79.58 | 0.457 |
| TG (mmol/L) | 1.39 ± 0.71 | 1.39 ± 0.70 | 1.41 ± 0.76 | 0.854 |
| LDL-C (mmol/L) | 1.90 ± 0.63 | 1.94 ± 0.67 | 1.84 ± 0.53 | 0.401 |
| LDL-C target | 59 (51.75%) | 37 (49.33%) | 22 (56.41%) | 0.473 |
| LVEF (%) | 59.76 ± 5.94 | 59.04 ± 6.42 | 61.15 ± 4.63 | 0.116 |
| DAPT | 61 (53.51%) | 42 (56.00%) | 19 (48.72) | 0.460 |
| Smoking | 0.958 | |||
| Never | 48 (42.11%) | 31 (41.33%) | 17 (43.59%) | |
| Currently | 23 (20.18%) | 15 (20.00%) | 8 (20.51%) | |
| Previously | 43 (37.72%) | 29 (38.67%) | 14 (35.90%) | |
| Drinking | 0.580 | |||
| Never | 64 (56.14%) | 42 (56.00%) | 22 (56.41%) | |
| Currently | 40 (35.09%) | 25 (33.33%) | 15 (38.46%) | |
| Previously | 10 (8.77%) | 8 (10.67%) | 2 (5.13%) | |
| Family history of CAD | 32 (28.07%) | 20 (26.67%) | 12 (30.77%) | 0.644 |
| Number of stents | 0.071 | |||
| 1 | 46 (40.35%) | 26 (34.67%) | 20 (51.28%) | |
| 2 | 32 (28.07%) | 18 (24.00%) | 14 (35.90%) | |
| 3 | 18 (15.79%) | 14 (18.67%) | 4 (10.26%) | |
| 4 | 10 (8.77%) | 10 (13.33%) | 0 (0.00%) | |
| 5 | 4 (3.51%) | 3 (4.00%) | 1 (2.56%) | |
| 6 | 1 (0.88%) | 1 (1.33%) | 0 (0.00%) | |
| 7 | 3 (2.63%) | 3 (4.00%) | 0 (0.00%) | |
| Vessels involved | 0.098 | |||
| 1 | 70 (61.40%) | 41 (54.67%) | 29 (74.36%) | |
| 2 | 36 (31.58%) | 27 (36.00%) | 9 (23.08%) | |
| 3 | 8 (7.02%) | 7 (9.33%) | 1 (2.56%) |
Note: Data are presented as the mean ± standard deviation for continuous variables and percentages for categorical variables.
Abbreviations: BMI, body mass index; CAD, coronary artery disease; caFFR, computational pressure-flow dynamics derived fractional flow reserve; DAPT, dual antiplatelet therapy; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricle ejection fraction; Scr, serum creatinine; rSS, residual SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score; TG, triglyceride.
The Symptoms, rSS, Exercise ECG and CCTA of the Study Participants
| caFFR | Positive (n=75) | Negative (n=39) | |
|---|---|---|---|
| Typical | 28 (37.33%) | 5 (12.82%) | 0.013 |
| Atypical | 15 (20.00%) | 13 (33.33%) | |
| Non-anginal | 11 (14.67%) | 12 (30.77%) | |
| Asymptomatic | 21 (28.00%) | 9 (23.08%) | |
| 7.33 ± 6.56 | 3.34 ± 4.26 | <0.001 | |
| 0.180 | |||
| Positive | 43 (57.33%) | 15 (38.46%) | |
| Suspicious positive | 16 (21.33%) | 9 (23.08%) | |
| Negative (Reach target) | 4 (5.33%) | 5 (12.82%) | |
| Negative (Not reach target) | 12 (16.00%) | 10 (25.64%) | |
| 59 (78.67%) | 24 (61.54%) | 0.051 | |
| 5.13 ± 2.00 | 5.84 ± 2.34 | 0.097 | |
| 67 (89.33%) | 18 (46.15%) | <0.001 |
Note: Data are presented as the mean ± standard deviation for continuous variables and percentages for categorical variables.
Abbreviations: CCTA, coronary computed tomography angiography; caFFR, computational pressure-flow dynamics derived fractional flow reserve; ECG, electrocardiogram; rSS, residual SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score; METs, metabolic equivalents.
Summary of the Diagnostic Parameters for Symptoms, Exercise ECG and CCTA
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) | AUC (%) (95% CI) | |
|---|---|---|---|---|---|---|
| Symptoms | 65.3 | 64.1 | 77.8 | 49.0 | 64.9 | 67.9 (58.0–77.8) |
| Exercise ECG | 78.7 | 38.5 | 71.1 | 48.4 | 64.9 | 58.6 (49.5–67.6) |
| CCTA | 89.3 | 53.9 | 78.8 | 72.4 | 77.2 | 71.6 (62.9–80.3) |
| Symptoms + Exercise ECG | 60.0 | 71.8 | 80.4 | 48.3 | 64.0 | 71.2 (61.3–81.0) |
| Symptoms + CCTA | 60.0 | 87.2 | 90.0 | 53.1 | 69.3 | 81.1 (73.1–89.0) |
| Exercise ECG + CCTA | 68.0 | 76.9 | 85.0 | 55.6 | 71.1 | 77.8 (68.9–86.7) |
| Symptoms + Exercise ECG + CCTA | 84.0 | 71.8 | 85.1 | 70.0 | 79.8 | 83.8 (76.1–91.6) |
Abbreviations: AUC, area under the curve; CCTA, coronary computed tomography angiography; CI, confidence interval; ECG, electrocardiogram; NPV, negative predictive values; PPV, positive predictive values.
Figure 1ROC for symptoms, Exercise ECG and CCTA.
Summary of Diagnostic Parameters for rSS, Symptoms, Exercise ECG and CCTA
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) | AUC (%) (95% CI) | |
|---|---|---|---|---|---|---|
| rSS(>8) | 39.4 | 89.5 | 87.5 | 44.2 | 56.9 | 64.5 (56.9–72.0) |
| Symptoms+rSS(>8) | 63.4 | 79.0 | 84.9 | 53.6 | 68.8 | 75.1 (65.5–84.7) |
| rSS(>8)+CCTA | 90.1 | 55.3 | 79.0 | 75.0 | 78.0 | 80.2 (72.5–87.8) |
| Symptoms+rSS(>8) + CCTA | 77.5 | 84.2 | 90.2 | 66.7 | 79.8 | 87.3 (80.3–94.3) |
| Symptoms+rSS(>8) +CCTA+ Exercise ECG | 90.1 | 73.7 | 86.5 | 80.0 | 84.4 | 88.1 (81.6–94.6) |
Abbreviations: AUC, area under the curve; CCTA, coronary computed tomography angiography; CI, confidence interval; ECG, electrocardiogram; NPV, negative predictive values; PPV, positive predictive values; rSS, RESidual synergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score.
Figure 2AUC and 95% CI of diagnostic parameters for rSS, symptoms, exercise ECG and CCTA.